ERNA

Eterna Therapeutics Inc. - Common Stock (ERNA)

About Eterna Therapeutics Inc. - Common Stock (ERNA)

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Details

Daily high
$0.18
Daily low
$0.17
Price at open
$0.18
52 Week High
$2.62
52 Week Low
$0.15
Market cap
11.5M
Dividend yield
0.00%
Volume
89,102
Avg. volume
226,746
P/E ratio
-.03

Eterna Therapeutics Inc. - Common Stock News

Details

Daily high
$0.18
Daily low
$0.17
Price at open
$0.18
52 Week High
$2.62
52 Week Low
$0.15
Market cap
11.5M
Dividend yield
0.00%
Volume
89,102
Avg. volume
226,746
P/E ratio
-.03